Results 221 to 230 of about 504,196 (405)

A Family of Cyclin-Like Proteins That Interact with the Pho85 Cyclin-Dependent Kinase [PDF]

, 1997
Vivien Measday, Lynda Moore, Ravi Retnakaran, Jonguk Lee, Michael S. Donoviel, Aaron M. Neiman, Brenda Andrews   +6 more
openalex   +1 more source

Therapeutic targeting of chromatin alterations in leukemia and solid tumors

International Journal of Cancer, EarlyView.
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner, Tobias Berg, Daniel Sasca, Sophie‐Luise Mersiowsky, Jayant Y. Gadrey, Johanna Thomas, Michael W. M. Kühn, Michael Lübbert   +7 more
wiley   +1 more source

Carcinogenic Potential of Benzene and Toluene When Evaluated Using Cyclin-Dependent Kinase Activation and p53-DNA Binding

, 1996
C. Dees, Minoo Askari, Don Henley
openalex   +1 more source

The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. [PDF]

, 1996
Corinne Cayrol, Erik K. Flemington
openalex   +1 more source

Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration

Proceedings of the National Academy of Sciences of the United States of America, 2012
M. K. Diril, Chandrahas Koumar Ratnacaram, V. Padmakumar, Tiehua Du, M. Wasser, V. Coppola, L. Tessarollo, P. Kaldis   +7 more
semanticscholar   +1 more source

Mass cytometric detection of homologous recombination proficiency in circulating tumor cells to predict chemoresistance of metastatic breast cancer patients

International Journal of Cancer, EarlyView.
What's New? Circulating tumor cells can offer insights into treatment responses and metastatic recurrence, but current analysis methods are limited. Here, the authors tested a newly developed mass cytometry panel comprising biomarkers such as γH2AX and RAD51 in longitudinally monitored metastatic breast cancer patients.
Kathrin Niedermayer, Henning Schäffler, Georgios Vlachos, Sara Greco, Kerstin Pfister, Barbara Volz, Leonie Ott, Hans Neubauer, Bernhard Polzer, André Koch, Sabine Riethdorf, Tanja Fehm, Wolfgang Janni, Thomas W. P. Friedl, Brigitte Rack, Ellen Heitzer, Fabienne Schochter, Lisa Wiesmüller   +17 more
wiley   +1 more source

Cyclin Dependent Kinase 2 (CDK2) Inhibitors in Oncology Clinical Trials: A Review. [PDF]

J Immunother Precis Oncol
House I, Valore-Caplan M, Maris E, Falchook GS.   +3 more
europepmc   +1 more source

Cell-Free Degradation of p27^kip1, a G₁ Cyclin-Dependent Kinase Inhibitor, Is Dependent on CDK2 Activity and the Proteasome

, 1999
Hoang M. Nguyen, Diana M. Gitig, Andrew Koff   +2 more
openalex   +1 more source

Cyclin-dependent protein kinase and cyclin homologs SSN3 and SSN8 contribute to transcriptional control in yeast. [PDF]

, 1995
Sergei Kuchin, Paula Yeghiayan, Marian Carlson   +2 more
openalex   +1 more source

Cyclin-Dependent Kinase Suppression by WEE1 Kinase Protects the Genome through Control of Replication Initiation and Nucleotide Consumption

Molecular and Cellular Biology, 2012
Halfdan Beck, Viola Nähse-Kumpf, M. S. Y. Larsen, K. O’Hanlon, S. Patzke, Christian Holmberg, Jakob Mejlvang, Anja Groth, O. Nielsen, R. Syljuåsen, C. Sørensen   +10 more
semanticscholar   +1 more source